Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119870) titled 'Clinical application value of 68Ga-FAPI-04 PET/CT or PET/MR in digestive system cancers' on March 4.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Chongqing University Cancer Hospital
Condition:
Esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer, cholangiocarcinoma, gallbladder cancer, small intestine cancer, etc.
Intervention:
Gold Standard:The reference criteria for the final diagnosis of primary, recurrent or metastatic lesions are biopsy or surgical pathological results, typical enhanced CT or MRI manifestations, or at least ...